… Serologic testing may aid in surveying asymptomatic infection, assessing past SARS-CoV-2 …
SARS-CoV-2 antibody responses (4, 13), yet this is the first report of SARS-CoV-2 antibody …

… responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection …
SARS-CoV-2 specific antibodies to provide neonatal protection from coronavirus disease 2019. …

… et al., 2020), and so RBD/S1 antibody levels are likely to reflect protective immunity. The …
SARS-CoV-2 antibody dynamics over a period of 8 months, and (ii) determine whether antibody …

… Our goal was to assess if the weak correlation is … virus neutralization to assess their
usefulness both in the measurement of SARS-CoV-2 Ig levels and confirmation of SARS-CoV-2 …

… of SARS-CoV-2, a blood serum sample (BD Vacutainer) was collected for analysis of antibodies.
… (Ig) A and IgG antibodies were considered to be positive for COVID-19. Patients were …

… antibodies in a high proportion of individuals who recovered from SARS-CoV-2 infection start
to decrease within 2–3 … antibody titers in eight convalescent patients with COVID-19, four …

… , CD4 + T cells, and CD8 + T cells can all participate in protective immunity to SARS-CoV-2,
we measured antigen-specific antibodies, memory B cells, CD4 + T cells, and CD8 + T cells …

… of different COVID-19 vaccine candidates challenging. … reagent for an anti-SARS-CoV-2
antibody. The availability of this … of immune response assessment across COVID-19 vaccine …

… check for immunization and assess herd immunity. We … antibodies directed to the SARS-CoV-2
Spike (S) antigen, either total (Wantaï SARS-CoV-2 Ab ELISA) or IgG (SARS-CoV-2 IgG II …

… Anti-SARS-CoV-2 Spike antibodies can be grouped in … antibodies (nAb), which develop in
close to 90% of patients and persist for at least 5 months. The nAbs isolated from SARS-CoV-2 …